High Effectiveness of the Bivalent Human Papillomavirus (HPV) Vaccine Against Incident and Persistent HPV Infections up to 6 Years after Vaccination in Young Dutch Women

Background Monitoring vaccine effectiveness (VE) in vaccination programs is of importance for assessing the impact of immunization. This study aimed to estimate the VE of the bivalent human papillomavirus (HPV) vaccine against incident and 12-month persistent infections up to 6 years after vaccination. Methods In 2009-2010, girls eligible for the vaccination catch-up campaign (ie, those aged 14-16 years) were enrolled into a prospective cohort. Annually, participants completed a questionnaire and submitted a self-collected vaginal swab sample for HPV testing by the SPF 10 -LiPA 25 assay. We co... Mehr ...

Verfasser: Donken, R.
King, A. J.
Bogaards, J. A.
Woestenberg, P. J.
Meijer, C. J. L. M.
de Melker, H. E.
Dokumenttyp: Artikel
Erscheinungsdatum: 2018
Reihe/Periodikum: Donken , R , King , A J , Bogaards , J A , Woestenberg , P J , Meijer , C J L M & de Melker , H E 2018 , ' High Effectiveness of the Bivalent Human Papillomavirus (HPV) Vaccine Against Incident and Persistent HPV Infections up to 6 Years after Vaccination in Young Dutch Women ' , Journal of Infectious Diseases , vol. 217 , no. 10 , pp. 1579-1589 . https://doi.org/10.1093/infdis/jiy067
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27076811
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://research.vumc.nl/en/publications/e8385a9b-b136-4ff3-a9d1-ed2d96f6ca24